Surgepays Change In Working Capital from 2010 to 2024
SURG Stock | USD 3.98 0.20 4.78% |
Change In Working Capital | First Reported 2006-12-31 | Previous Quarter -3 M | Current Value 642.2 K | Quarterly Volatility 3.4 M |
Check Surgepays financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgepays main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 1.1 M or Selling General Administrative of 16.3 M, as well as many exotic indicators such as Price To Sales Ratio of 0.64, Dividend Yield of 0.0 or PTB Ratio of 3.42. Surgepays financial statements analysis is a perfect complement when working with Surgepays Valuation or Volatility modules.
Surgepays | Change In Working Capital |
Latest Surgepays' Change In Working Capital Growth Pattern
Below is the plot of the Change In Working Capital of Surgepays over the last few years. It is the difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities. Surgepays' Change In Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Surgepays' overall financial position and show how it may be relating to other accounts over time.
Change In Working Capital | 10 Years Trend |
|
Change In Working Capital |
Timeline |
Surgepays Change In Working Capital Regression Statistics
Arithmetic Mean | (3,339,543) | |
Coefficient Of Variation | (238.89) | |
Mean Deviation | 5,720,148 | |
Median | 9,787 | |
Standard Deviation | 7,977,867 | |
Sample Variance | 63.6T | |
Range | 29.8M | |
R-Value | (0.62) | |
Mean Square Error | 42.4T | |
R-Squared | 0.38 | |
Significance | 0.01 | |
Slope | (1,100,929) | |
Total Sum of Squares | 891T |
Surgepays Change In Working Capital History
About Surgepays Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Surgepays income statement, its balance sheet, and the statement of cash flows. Surgepays investors use historical funamental indicators, such as Surgepays's Change In Working Capital, to determine how well the company is positioned to perform in the future. Although Surgepays investors may use each financial statement separately, they are all related. The changes in Surgepays's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Surgepays's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Surgepays Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Surgepays. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Change In Working Capital | -13.9 M | -13.2 M |
Currently Active Assets on Macroaxis
VWITX | Vanguard Intermediate Term Tax Exempt | |
VGSTX | Vanguard Star Fund | |
VFIAX | Vanguard 500 Index | |
VTCLX | Vanguard Tax Managed Capital | |
VTSAX | Vanguard Total Stock |
Check out the analysis of Surgepays Correlation against competitors. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Surgepays Stock analysis
When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Surgepays' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.17) | Earnings Share 1.38 | Revenue Per Share 9.618 | Quarterly Revenue Growth (0.11) | Return On Assets 0.3106 |
The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.